Publications
More than 100 specialist publications in scientific journals:
1. Kraupp, M., et al., Adenine and hypoxanthine transport in human erythrocytes: distinct substrate effects on carrier mobility. Biochim Biophys Acta, 1991. 1070(1): p. 157-62.
2. Prager, G., R. Prager, and P. Klein, Comparison of the twenty-four-hour blood pressure profile in elderly subjects with isolated systolic hypertension, essential hypertension and normotension. J Hypertens Suppl, 1991. 9(6): p. S102-3.
3. Passler, C., et al., Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg, 1999. 384(3): p. 284-93.
4. Prager, G., et al., [The value of preoperative localization studies in primary hyperparathyroidism]. Chirurg, 1999. 70(10): p. 1082-8.
5. Scheuba, C., et al., Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery, 1999. 126(6): p. 1089-95; discussion 1096.
6. Neunteufl, T., et al., Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf), 2000. 53(2): p. 229-33.
7. Felberbauer, F.X., G. Prager, and E. Wenzl, The inflatable band and exercise machines. Obes Surg, 2001. 11(4): p. 532.
8. Prager, G., et al., Minimally invasive open parathyroidectomy in an endemic goiter area: a prospective study. Arch Surg, 2001. 136(7): p. 810-6.
9. Zettinig, G., et al., Images in thyroidology. A man with a 99mTc-pertechnetate-enhancing mediastinal mass. Thyroid, 2001. 11(8): p. 805.
10. Bieglmayer, C., G. Prager, and B. Niederle, Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem, 2002. 48(10): p. 1731-8.
11. Hoda, M.R., et al., [Pregnancy and labor after adjustable gastric banding for therapy of morbid obesity]. Wien Klin Wochenschr, 2002. 114(17-18): p. 781-4.
12. Honigschnabl, S., et al., How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol, 2002. 41(2): p. 113-22.
13. Kaczirek, K., et al., Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment. Wien Klin Wochenschr, 2002. 114(7): p. 258-66.
14. Passler, C., et al., Thyroid surgery in the geriatric patient. Arch Surg, 2002. 137(11): p. 1243-8.
15. Prager, G., et al., Surgical strategy in adrenal masses. Eur J Radiol, 2002. 41(1): p. 70-7.
16. Prager, G., et al., Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses? World J Surg, 2002. 26(8): p. 958-64.
17. Prager, G., et al., Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery, 2002. 132(6): p. 930-5; discussion 935-6.
18. Schindl, M., et al., Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified? World J Surg, 2002. 26(8): p. 976-84.
19. Zettinig, G., et al., 'Suppressed' double adenoma--a rare pitfall in minimally invasive parathyroidectomy. Horm Res, 2002. 57(1-2): p. 57-60.
20. Zettinig, G., et al., [Value of a structured report for the interpretation of parathyroid scintigraphy in primary essential hyperthyroidism]. Acta Med Austriaca, 2002. 29(2): p. 68-71.
21. Heinz-Peer, G., et al., [Imaging of tumours of the adrenal gland]. Wien Klin Wochenschr, 2003. 115 Suppl 2: p. 65-70.
22. Kaczirek, K., et al., Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin, 2003. 42(5): p. 220-3.
23. Kaczirek, K., et al., Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. Eur J Clin Invest, 2003. 33(6): p. 488-92.
24. Niederle, B., et al., [Minimally invasive endocrine surgery: aspects of diagnostic imaging]. Wien Klin Wochenschr, 2003. 115 Suppl 2: p. 10-8.
25. Passler, C., et al., Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg, 2003. 237(2): p. 227-34.
26. Passler, C., et al., Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg, 2003. 138(12): p. 1362-6.
27. Prager, G., et al., Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg, 2003. 196(4): p. 541-8.
28. Prager, G., et al., The role of intraoperative quick PTH measurements in primary hyperparathyroidism. Ann Ital Chir, 2003. 74(4): p. 395-9.
29. Rauhofer, U., et al., Cystic echinococcosis of the thyroid gland in children and adults. Thyroid, 2003. 13(5): p. 497-502.
30. Saeger, W., et al., High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol, 2003. 34(2): p. 180-6.
31. Stift, A., et al., The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue. Int J Oncol, 2003. 23(5): p. 1269-75.
32. Bohdjalian, A., et al., [Surgical treatment of obesity]. Wien Med Wochenschr, 2004. 154(13-14): p. 329-33.
33. Kaczirek, K., et al., Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines. J Clin Endocrinol Metab, 2004. 89(5): p. 2397-401.
34. Passler, C., et al., Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer, 2004. 11(1): p. 131-9.
35. Prager, G., et al., Applicability of laparoscopic adrenalectomy in a prospective study in 150 consecutive patients. Arch Surg, 2004. 139(1): p. 46-9.
36. Schindler, K., et al., Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest, 2004. 34(8): p. 549-54.
37. Stadler, A., et al., CT density measurements for characterization of adrenal tumors ex vivo: variability among three CT scanners. AJR Am J Roentgenol, 2004. 182(3): p. 671-5.
38. Widhalm, K., S. Dietrich, and G. Prager, Adjustable gastric banding surgery in morbidly obese adolescents: experiences with eight patients. Int J Obes Relat Metab Disord, 2004. 28 Suppl 3: p. S42-5.
39. Fleischmann, E., et al., Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg, 2005. 15(6): p. 813-9.
40. Kaczirek, K., et al., Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery, 2005. 137(4): p. 431-5.
41. Langer, F.B., et al., Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg, 2005. 15(7): p. 1024-9.
42. Langer, F.B., et al., Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg, 2005. 79(2): p. 398-403; discussion 404.
43. Bieglmayer, C., et al., Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem, 2006. 52(6): p. 1112-9.
44. Bohdjalian, A., et al., One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg, 2006. 16(5): p. 627-34.
45. Haider, D.G., et al., Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol Endocrinol Metab, 2006. 291(5): p. E885-90.
46. Haider, D.G., et al., Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab, 2006. 91(4): p. 1578-81.
47. Kaczirek, K., et al., Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Arch Surg, 2006. 141(2): p. 129-34; discussion 134.
48. Langer, F.B., et al., Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg, 2006. 16(2): p. 166-71.
49. Silberhumer, G.R., et al., Laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg, 2006. 16(8): p. 1062-7.
50. Anderwald, C., et al., The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care, 2007. 30(9): p. 2374-80.
51. Haider, D.G., et al., Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab, 2007. 9(5): p. 761-3.
52. Haider, D.G., et al., Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab, 2007. 92(3): p. 1168-71.
53. Lenglinger, J., G. Prager, and M. Riegler, Adequate biopsy sampling for exclusion of columnar-lined esophagus in the obese. Obes Surg, 2007. 17(7): p. 993; author reply 994.
54. Lenglinger, J., et al., Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2007. 119(13-14): p. 405-11.
55. Ringhofer, C., et al., Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2007. 119(9-10): p. 283-90.
56. Felberbauer, F.X., et al., Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers. Obes Surg, 2008. 18(7): p. 814-8.
57. Huber, J., et al., CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab, 2008. 93(8): p. 3215-21.
58. Kiefer, F.W., et al., Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology, 2008. 149(3): p. 1350-7.
59. Langer, F.B., et al., Inadequate weight loss vs secondary weight regain: laparoscopic conversion from gastric banding to Roux-en-Y gastric bypass. Obes Surg, 2008. 18(11): p. 1381-6.
60. Riedl, M., et al., Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab, 2008. 93(6): p. 2307-12.
61. Ringhofer, C., et al., Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2008. 120(11-12): p. 350-9.
62. Silberhumer, G.R., et al., Design and instrumentation of new devices for performing appendectomy at colonoscopy (with video). Gastrointest Endosc, 2008. 68(1): p. 139-45.
63. Widhalm, K., et al., Bariatric surgery in morbidly obese adolescents: a 4-year follow-up of ten patients. Int J Pediatr Obes, 2008. 3 Suppl 1: p. 78-82.
64. Bohdjalian, A., et al., Circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg, 2009. 20(4): p. 440-6.
65. Bohdjalian, A., et al., Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc, 2009. 23(9): p. 1955-60.
66. Bohdjalian, A., et al., Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Obes Surg, 2009. 19(9): p. 1221-7.
67. Schoppmann, S.F., et al., Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer Res, 2009. 29(7): p. 2719-25.
68. Shakeri-Manesch, S., et al., Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond), 2009.
69. Silberhumer, G.R., et al., The Value of Protecting the Longitudinal Staple Line with Invaginating Sutures during Esophageal Reconstruction by Gastric Tube Pull-Up. Dig Surg, 2009. 26(4): p. 337-341.
70. Silberhumer, G.R., et al., Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg, 2009. 13(7): p. 1213-9.
71. Vila, G., et al., Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring), 2009. 17(6): p. 1184-8.
72. Bohdjalian, A., et al., Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin. Obes Surg, 2010.
73. Handisurya, A., et al., Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg, 2010. 20(2): p. 198-203.
74. Kabon, B., et al., Supplemental postoperative oxygen and tissue oxygen tension in morbidly obese patients. Obes Surg, 2010. 20(7): p. 885-94.
75. Langer, F.B., et al., Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass--indications and outcome. Obes Surg, 2010. 20(7): p. 835-40.
76. Langer, F.B., et al., Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. Ann Thorac Surg, 2010. 89(5): p. 1691-2.
77. Langer, F.B., et al., Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol, 2010. 17(2): p. 470-5.
78. Langer, F.B., et al., Strategies for weight regain after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech, 2010. 20(3): p. 159-61.
79. Pospisilik, J.A., et al., Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell, 2010. 140(1): p. 148-60.
80. Rieder, E., et al., Mesh fixation in laparoscopic incisional hernia repair: glue fixation provides attachment strength similar to absorbable tacks but differs substantially in different meshes. J Am Coll Surg, 2010. 212(1): p. 80-6.
81. Schoppmann, S.F., et al., Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc, 2010.
82. Zeyda, M., et al., Inflammation Correlates With Markers of T-Cell Subsets Including Regulatory T Cells in Adipose Tissue From Obese Patients. Obesity (Silver Spring), 2010.
83. Kitzinger, H.B., et al., The Prevalence of Body Contouring Surgery After Gastric Bypass Surgery. Obesity surgery, 2011.
84. Promintzer-Schifferl, M., et al., Effects of Gastric Bypass Surgery on Insulin Resistance and Insulin Secretion in Nondiabetic Obese Patients. Obesity (Silver Spring), 2011.
85. Rieder, E., et al., Mesh fixation in laparoscopic incisional hernia repair: glue fixation provides attachment strength similar to absorbable tacks but differs substantially in different meshes. Journal of the American College of Surgeons, 2011. 212(1): p. 80-6.
86. Silberhumer, G.R., et al., Long-term results after laparoscopic adjustable gastric banding in adolescent patients: follow-up of the Austrian experience. Surgical endoscopy, 2011. 25(9): p. 2993-9.
87. Todoric, J., et al., Cross-talk between interferon-gamma and hedgehog signaling regulates adipogenesis. Diabetes, 2011. 60(6): p. 1668-76.
88. Vila, G., et al., The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem, 2011. 57(2): p. 309-16.
89. Widhalm, K., et al., Bariatric surgery in morbidly obese adolescents: long-term follow-up. International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity, 2011. 6 Suppl 1: p. 65-9.
90. Zeyda, M., et al., Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function. Endocrinology, 2011.
91. Zeyda, M., et al., Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity, 2011. 19(4): p. 743-8.
92. Anderwald, C.H., et al., Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes Care, 2012. 35(12): p. 2580-7.
93. Bohdjalian, A., et al., Gastric Stimulation in the Digestive Period Modifies Length and Contractility of the Inter-digestive Period in Obese Non-diabetic and Diabetic Subjects. Obesity surgery, 2012.
94. Itariu, B.K., et al., Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr, 2012. 96(5): p. 1137-49.
95. Jankovic, D., et al., Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obesity surgery, 2012. 22(1): p. 62-9.
96. Kitzinger, H.B., et al., After massive weight loss: patients' expectations of body contouring surgery. Obesity surgery, 2012. 22(4): p. 544-8.
97. Kitzinger, H.B., et al., The prevalence of body contouring surgery after gastric bypass surgery. Obesity surgery, 2012. 22(1): p. 8-12.
98. Rosenthal, R.J., et al., International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2012. 8(1): p. 8-19.
99. Schoppmann, S.F., et al., Outcome and complications of long-term self-expanding esophageal stenting. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E, 2012.
100. Zeyda, M., et al., Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. International journal of obesity, 2012.
101. Langer, F.B., et al., Weight loss and weight regain-5-year follow-up for circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg, 2013. 23(6): p. 776-81.
102. Lindroos, J., et al., Human but Not Mouse Adipogenesis Is Critically Dependent on LMO3. Cell Metab, 2013. 18(1): p. 62-74.
103. Schoppmann, S.F., et al., Outcome and complications of long-term self-expanding esophageal stenting. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E, 2013. 26(2): p. 154-8.
104. Schwameis, K., et al., The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. Anticancer Res, 2013. 33(5): p. 2085-91.
105. Zeyda, M., et al., Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond), 2013. 37(5): p. 658-65.
106. Borsoi, L., et al., Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery. Obes Facts, 2014. 7(3): p. 191-6.
107. Itariu, B.K., et al., Insulin-Like Growth Factor 1 Predicts Post-Load Hypoglycemia following Bariatric Surgery: A Prospective Cohort Study. PLoS One, 2014. 9(4): p. e94613.